351. Accuracy of predicted effective orifice area in determining incidence of patient-prosthesis mismatch after transcatheter aortic valve replacement
- Author
-
Jacinda Berg, Elana Koss, Pey-Jen Yu, Michael A. Catalano, Greg Maurer, Alan R. Hartman, and Bruce Rutkin
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Transcatheter aortic ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,Transesophageal echocardiogram ,Prosthesis Design ,Prosthesis ,Transcatheter Aortic Valve Replacement ,03 medical and health sciences ,0302 clinical medicine ,Aortic valve replacement ,Valve replacement ,Internal medicine ,medicine ,Humans ,Retrospective Studies ,Body surface area ,Heart Valve Prosthesis Implantation ,medicine.diagnostic_test ,Effective orifice area ,business.industry ,Incidence (epidemiology) ,Incidence ,Aortic Valve Stenosis ,medicine.disease ,Treatment Outcome ,030228 respiratory system ,Aortic Valve ,Heart Valve Prosthesis ,Cardiology ,Quality of Life ,Surgery ,Cardiology and Cardiovascular Medicine ,business - Abstract
Objective Patient-prosthesis mismatch (PPM) is associated with poor outcomes after aortic valve replacement. The aim of this study was to assess the accuracy of indexed effective orifice area (EOAi) charts in predicting PPM after transcatheter aortic valve replacement (TAVR). Methods A retrospective review of 346 TAVR patients from January 2017 to November 2018 was performed. EOAi was predicted for patients based on published predictive tables using valve type, annulus diameter, and body surface area. Actual EOAi was calculated based on intraoperative transesophageal echocardiogram (TEE) measurements. PPM was defined by EOAi ≤ 0.85 cm2 /m2 . The accuracy of predicted PPM was assessed. Differences in clinical outcomes, including mean gradient, length of stay, mortality, complications, and change in Kansas City cardiomyopathy questionnaire score as an indicator of quality of life, were evaluated based on actual PPM. Results Of the 346 patients analyzed, 44 (12.7%) of patients had PPM on intraoperative TEE. Of the 182 patients who received Sapien 3 valves, 42 (23.1%) were predicted to have PPM while 25 (13.7%) had actual PPM. Of the 164 patients who received Evolut valves, 3 (1.8%) were predicted to have PPM while 19 (11.6%) had actual PPM. EOAi charts had poor sensitivity (40.0% for Sapien 3; 5.25% for Evolut) and positive predictive value (23.8% for Sapien 3; 33.3% for Evolut) for both valve types. Conclusion Preoperative prediction of PPM in TAVR patients using tables of expected EOA demonstrates significant variation from actual PPM. The utility of EOAi charts to predict PPM in patients undergoing TAVR may be limited.
- Published
- 2020